Compugen Stock

Compugen PEG

The PEG Ratio (Price/Earnings-to-Growth) of Compugen (CGEN) as of Sep 4, 2026 is 0.02. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was -0.76 — a change of -102.76% (higher).

PEG

0.02

YoY

-102.76%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Compugen is 2026 0.02 . PEG Ratio (Price/Earnings-to-Growth) of Compugen was 2025 -0.76 . It decreases by -102.76% higher compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

PEG Ratio (Price/Earnings-to-Growth) of Compugen is 0.02 in 2026.

PEG Ratio (Price/Earnings-to-Growth) of Compugen changed from -0.76 to 0.02, representing a -102.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Compugen since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Compugen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Compugen

All Key Metrics — Compugen